Am J Psychiatry 157:867-876, June 2000
© 2000 American Psychiatric Association
Neuropsychiatric Symptoms Associated With Hepatitis C and Interferon Alpha: A Review
Eric Dieperink, M.D.,
Mark Willenbring, M.D., and
Samuel B. Ho, M.D.
ABSTRACT
OBJECTIVE: Neuropsychiatric symptoms are commonly associated with chronic hepatitis C virus infection, its sequelae, and its treatment. In particular, interferon, a primary component of treatment for chronic hepatitis C, has been strongly associated with depressive symptoms. This review summarizes current knowledge about the etiology, course, and treatment of neuropsychiatric problems associated with hepatitis C and interferon alpha (IFN- ) treatment. METHOD: Studies were identified by computerized searches, and further references were obtained from bibliographies of the reviewed articles. RESULTS: Chronic infection with the hepatitis C virus is a common and growing problem, often affecting persons with psychiatric and substance use problems. Although changes in cognition, mood, and personality have been described in association with hepatitis C and with IFN- treatment, there has been little systematic study of these changes. CONCLUSIONS: Psychiatrists should become familiar with the clinical spectrum associated with hepatitis C virus infection as well as the neuropsychiatric symptoms related to hepatitis C and IFN- treatment. More studies are necessary to define the neuropsychiatric syndromes associated with this population and to find possible effective treatments. Furthermore, research is needed so that patients with psychiatric problems are not excluded from effective treatments for this growing medical problem.
This article has been cited by other articles:
|
|
|
|
 
M. Schaefer, J. Winterer, R. Sarkar, R. Uebelhack, L. Franke, A. Heinz, and A. Friebe
Three Cases of Successful Tryptophan Add-On or Monotherapy of Hepatitis C and IFN{alpha}-Associated Mood Disorders
Psychosomatics,
September 1, 2008;
49(5):
442 - 446.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. R. Beckwith
The Precipitation of Mania by Citalopram in a Patient With Interferon-Induced Depression
Psychosomatics,
July 1, 2008;
49(4):
362 - 363.
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Dieperink, J. Leskela, M. E. Dieperink, B. Evans, P. Thuras, and S. B. Ho
The Effect of Pegylated Interferon-{alpha}2b and Ribavirin on Posttraumatic Stress Disorder Symptoms
Psychosomatics,
May 1, 2008;
49(3):
225 - 229.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E Murray and D Jones
Audit into blood-borne virus services in Her Majesty's Prison Service
Int J STD AIDS,
May 1, 2008;
19(5):
347 - 348.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M R Kraus, A Schafer, K Schottker, C Keicher, B Weissbrich, I Hofbauer, and M Scheurlen
Therapy of interferon-induced depression in chronic hepatitis C with citalopram: a randomised, double-blind, placebo-controlled study
Gut,
April 1, 2008;
57(4):
531 - 536.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Bannink, W. H.J. Kruit, A. R. Van Gool, S. Sleijfer, B. van der Holt, A. M.M. Eggermont, G. Stoter, and M. W. Hengeveld
Interferon-{alpha} in Oncology Patients: Fewer Psychiatric Side Effects Than Anticipated
Psychosomatics,
February 1, 2008;
49(1):
56 - 63.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Freudenreich, R. T. Gandhi, J. P. Walsh, D. C. Henderson, and D. C. Goff
Hepatitis C in Schizophrenia: Screening Experience in a Community-Dwelling Clozapine Cohort
Psychosomatics,
October 1, 2007;
48(5):
405 - 411.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. P. Mundt, R. Sarkar, C. Winter, M. Schaefer, and A. Strohle
Exacerbation of Psychogenic Movement Disorder by Interferon{alpha} Treatment of Hepatitis C
Psychosomatics,
February 1, 2007;
48(1):
86 - 87.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Horsmans
Interferon-induced depression in chronic hepatitis C
J. Antimicrob. Chemother.,
October 1, 2006;
58(4):
711 - 713.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Bourgeois, R. Canning, K. Suggett, C. C. Chambers, N. Rahim, and L. Rossaro
Depressive Symptoms and Physical/Mental Functioning With Interferon/Ribavirin Treatment of Posttransplant Recurrent Hepatitis C
Psychosomatics,
June 1, 2006;
47(3):
254 - 256.
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. A. Mistler, M. F. Brunette, B. J. Marsh, R. M. Vidaver, R. Luckoor, and S. D. Rosenberg
Hepatitis C treatment for people with severe mental illness.
Psychosomatics,
March 1, 2006;
47(2):
93 - 107.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Balasubramanian, C.C. Prosser, K. Ransibrahmanakul, L. Rossaro, and J.A. Bourgeois
Treatment of hepatitis B and C co-infection in schizoaffective disorder
QJM,
October 1, 2005;
98(10):
774 - 775.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. P. Yovtcheva, M. A. Rifai, J. K. Moles, and B. J. Van Der Linden
Psychiatric Comorbidity Among Hepatitis C-Positive Patients
Focus,
April 1, 2005;
3(2):
261 - 265.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. M. Asnis, A. L. Migdal, E. L. Ryan, D. Dieterich, and S. Morgello
Neuropsychiatric impact of hepatitis C on advanced HIV
Neurology,
February 22, 2005;
64(4):
768 - 768.
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. A. Kalyoncu, D. Tan, H. Mirsal, O. Pektas, and M. Beyazyurek
Major depressive disorder with psychotic features induced by interferon-{alpha} treatment for hepatitis C in a polydrug abuser
J Psychopharmacol,
January 1, 2005;
19(1):
102 - 105.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S. C. Matthews, M. P. Paulus, and J. E. Dimsdale
Contribution of Functional Neuroimaging to Understanding Neuropsychiatric Side Effects of Interferon in Hepatitis C
Psychosomatics,
August 1, 2004;
45(4):
281 - 286.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Russo, J. C. Boon, I. P. Kema, P. H.B. Willemse, J. A. den Boer, J. Korf, and E. G.E. de Vries
Patients With Carcinoid Syndrome Exhibit Symptoms of Aggressive Impulse Dysregulation
Psychosom Med,
May 1, 2004;
66(3):
422 - 425.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Nagano, S. Nagase, N. Sudo, and C. Kubo
Psychosocial Stress, Personality, and the Severity of Chronic Hepatitis C
Psychosomatics,
April 1, 2004;
45(2):
100 - 106.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. A. Gochee, E. E. Powell, D. M. Purdie, N. Pandeya, L. Kelemen, C. Shorthouse, J. R. Jonsson, and B. Kelly
Association Between Apolipoprotein E {epsilon}4 and Neuropsychiatric Symptoms During Interferon {alpha} Treatment for Chronic Hepatitis C
Psychosomatics,
February 1, 2004;
45(1):
49 - 57.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. G. Hoffman, M. A. Cohen, C. A. Alfonso, J. J. Weiss, S. Jones, M. Keller, J. R. Condemarin, N.-M. Chiu, and J. M. Jacobson
Treatment of Interferon-Induced Psychosis in Patients With Comorbid Hepatitis C and HIV
Psychosomatics,
October 1, 2003;
44(5):
417 - 420.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. K. Al Jurdi and J. W. Burruss
Prevalence of Hepatitis C in Psychiatric Institutions
Psychosomatics,
October 1, 2003;
44(5):
439 - 440.
[Full Text]
|
|
|
|
|
|
|
K. Yoshida, H. Higuchi, H. Takahashi, and T. Shimizu
Favorable Effect of Milnacipran on Depression Induced by Interferon-Alpha
J Neuropsychiatry Clin Neurosci,
May 1, 2003;
15(2):
242 - 243.
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Dieperink, S. B. Ho, P. Thuras, and M. L. Willenbring
A Prospective Study of Neuropsychiatric Symptoms Associated With Interferon-{alpha}-2b and Ribavirin Therapy for Patients With Chronic Hepatitis C
Psychosomatics,
April 1, 2003;
44(2):
104 - 112.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Tamam, D. Yerdelen, and N. Ozpoyraz
Psychosis Associated with Interferon Alfa Therapy for Chronic Hepatitis B
Ann. Pharmacother.,
March 1, 2003;
37(3):
384 - 387.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. H. Dinwiddie, L. Shicker, and T. Newman
Prevalence of Hepatitis C Among Psychiatric Patients in the Public Sector
Am J Psychiatry,
January 1, 2003;
160(1):
172 - 174.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Garcia-Pares, C. Domenech, and M. Gil
Psychosis Induced by Interferon-{alpha}
Psychosomatics,
October 1, 2002;
43(5):
428 - 429.
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. I. Okereke
Neuropsychiatric Complications Associated With Interferon-Alpha-2b Treatment of Malignant Melanoma
Psychosomatics,
June 1, 2002;
43(3):
237 - 240.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. P. Yovtcheva, M. A. Rifai, J. K. Moles, and B. J. Van Der Linden
Psychiatric Comorbidity Among Hepatitis C-Positive Patients
Psychosomatics,
October 1, 2001;
42(5):
411 - 415.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Gallucci and J. Smolinski
Treatment Contracts for Patients With Hepatitis C, Psychiatric Illness, and Substance Abuse
Psychosomatics,
August 1, 2001;
42(4):
353 - 355.
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. R. Edlin, K. H. Seal, J. Lorvick, A. H. Kral, D. H. Ciccarone, L. D. Moore, and B. Lo
Is It Justifiable to Withhold Treatment for Hepatitis C from Illicit-Drug Users?
N. Engl. J. Med.,
July 19, 2001;
345(3):
211 - 214.
[Full Text]
[PDF]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 2000
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
